PAIA’s novel technology streamlines bead-based assays by eliminating several assay steps with specially designed microplates, leading to reduced hands-on time and a fully automatable workflow.
We offer assay kits comprising PAIA plates and a combination of functionalised capture beads and a fluorescence marker which is optimised for a given application. Our different antibody quantification assays cover the typical concentrations ranges at the different stages of cell line and bioprocess development. The samples can be measured directly from supernatant without dilution or any sample preparation step.
PAIA glycan assays use the same general principle and workflow, but employ markers specific for the glycans present on the antibody or protein of interest.
PAIA assays require a common orbital shakers for incubation and a standard fluorescence readers or microscope for analysis.
PAIA NEWS & INSIGHTS
E-Newsletters, News, PAIA, Sy-labFebruary 28, 2022
Cell Line Development, Insights, News, PAIAOctober 6, 2021
My Dream CLD Lab – Part 4: PAIA product titer and glycosylation screening assays
cytena, E-Newsletters, News, PAIA, SYNENTECFebruary 18, 2021
Application Notes, Cell Line Development, News, PAIA, SYNENTECFebruary 18, 2021
Unleash the potential of your CLD platform
cytena, E-Newsletters, News, PAIA, SYNENTECNovember 26, 2020
News, PAIAOctober 2, 2018
Optimising cell culture processes with PAIA IgG quantification assays